Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1245246

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1245246

North America Cardiovascular Digital Solutions Market Size, Share & Industry Trends Analysis Report By Service Type, By End-use, By Deployment, By Components, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Cardiovascular Digital Solutions Market would witness market growth of 3.6% CAGR during the forecast period (2022-2028).

Digital solutions have become a suitable accompaniment to traditional medicine due to their many advantages. These include simplicity of use, shortened development times, flexible delivery platforms, lower treatment costs, personalized treatment options, and improved medication adherence. The overall market is anticipated to increase consistently over time, given the advantages provided by these solutions and the increased desire for digital and remote solutions globally following the pandemic.

Ischemic heart disease, cardiomyopathies, cerebrovascular disease, arrhythmias, rheumatic heart disease, peripheral vascular disease, congenital heart disease, hypertensive heart disease, and other disorders are included in the broad category of CVD. Although non-modifiable factors (such as genetics, age, and sex) are equally significant, most CVD is hastened by mainly metabolic risk factors and modifiable behavioral. The majority of available scientific data currently favors the application of digital technologies in the treatment and management of CVD.

A significant shift has taken place in the US in Cardiovascular care from volume-based, fee-for-service (FFS) payment models to those centered on quality as well as patient outcomes. As a result, value-based care (VBC) payment schemes are available in a spectrum of risk and competency requirements. The transition to VBC payment structures is altering the economics of cardiology providers and putting MedTech manufacturers at risk of commercialization unless they produce unique, significant solutions. In order to encourage new financial structures and provider incentives, MedTech companies are now developing cardiovascular solutions that have clinical and financial value in addition to product performance. Therefore, in the coming years, the expedited incorporation of digital solutions presents robust growth opportunities for the regional market's growth.

The US market dominated the North America Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $34,667.6 Million by 2028. The Canada market is poised to grow at a CAGR of 6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.1% during (2022 - 2028).

Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.

Scope of the Study

Market Segments covered in the Report:

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Deployment

  • Cloud-Based
  • On-premise

By Components

  • Devices
  • Software

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Apple, Inc.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Verily Life Sciences LLC (Alphabet, Inc.)
  • iRhythm Technologies, Inc.
  • Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
  • eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
  • AliveCor, Inc.
  • Cardiotrack
  • HeartFlow, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Cardiovascular Digital Solutions Market, by Service Type
    • 1.4.2 North America Cardiovascular Digital Solutions Market, by End-use
    • 1.4.3 North America Cardiovascular Digital Solutions Market, by Deployment
    • 1.4.4 North America Cardiovascular Digital Solutions Market, by Components
    • 1.4.5 North America Cardiovascular Digital Solutions Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players

Chapter 4. North America Cardiovascular Digital Solutions Market by Service Type

  • 4.1 North America Unobtrusive Testing Market by Country
  • 4.2 North America CVD Health Informatics Market by Country
  • 4.3 North America Cardiac Rehab Programs Market by Country
  • 4.4 North America Others Market by Country

Chapter 5. North America Cardiovascular Digital Solutions Market by End-use

  • 5.1 North America Hospitals & Clinics Market by Country
  • 5.2 North America Ambulatory Care Centers Market by Country
  • 5.3 North America Others Market by Country

Chapter 6. North America Cardiovascular Digital Solutions Market by Deployment

  • 6.1 North America Cloud-Based Market by Country
  • 6.2 North America On-premise Market by Country

Chapter 7. North America Cardiovascular Digital Solutions Market by Components

  • 7.1 North America Devices Market by Country
  • 7.2 North America Software Market by Country

Chapter 8. North America Cardiovascular Digital Solutions Market by Country

  • 8.1 US Cardiovascular Digital Solutions Market
    • 8.1.1 US Cardiovascular Digital Solutions Market by Service Type
    • 8.1.2 US Cardiovascular Digital Solutions Market by End-use
    • 8.1.3 US Cardiovascular Digital Solutions Market by Deployment
    • 8.1.4 US Cardiovascular Digital Solutions Market by Components
  • 8.2 Canada Cardiovascular Digital Solutions Market
    • 8.2.1 Canada Cardiovascular Digital Solutions Market by Service Type
    • 8.2.2 Canada Cardiovascular Digital Solutions Market by End-use
    • 8.2.3 Canada Cardiovascular Digital Solutions Market by Deployment
    • 8.2.4 Canada Cardiovascular Digital Solutions Market by Components
  • 8.3 Mexico Cardiovascular Digital Solutions Market
    • 8.3.1 Mexico Cardiovascular Digital Solutions Market by Service Type
    • 8.3.2 Mexico Cardiovascular Digital Solutions Market by End-use
    • 8.3.3 Mexico Cardiovascular Digital Solutions Market by Deployment
    • 8.3.4 Mexico Cardiovascular Digital Solutions Market by Components
  • 8.4 Rest of North America Cardiovascular Digital Solutions Market
    • 8.4.1 Rest of North America Cardiovascular Digital Solutions Market by Service Type
    • 8.4.2 Rest of North America Cardiovascular Digital Solutions Market by End-use
    • 8.4.3 Rest of North America Cardiovascular Digital Solutions Market by Deployment
    • 8.4.4 Rest of North America Cardiovascular Digital Solutions Market by Components

Chapter 9. Company Profiles

  • 9.1 Apple, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 General Electric Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
      • 9.2.5.3 Acquisition and Mergers:
  • 9.3 Koninklijke Philips N.V.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
      • 9.3.5.3 Acquisition and Mergers:
  • 9.4 Verily Life Sciences LLC (Alphabet, Inc.)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 iRhythm Technologies, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Research & Development Expense
  • 9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Product Launches and Product Expansions:
  • 9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental Analysis
  • 9.8 AliveCor, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Recent strategies and developments:
      • 9.8.2.1 Partnerships, Collaborations, and Agreements:
      • 9.8.2.2 Product Launches and Product Expansions:
  • 9.9 Cardiotrack
    • 9.9.1 Company Overview
  • 9.10. HeartFlow, Inc.
    • 9.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 North America Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 2 North America Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cardiovascular Digital Solutions Market
  • TABLE 4 Product Launches And Product Expansions- Cardiovascular Digital Solutions Market
  • TABLE 5 Acquisition and Mergers- Cardiovascular Digital Solutions Market
  • TABLE 6 North America Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 7 North America Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 8 North America Unobtrusive Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 9 North America Unobtrusive Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 10 North America CVD Health Informatics Market by Country, 2018 - 2021, USD Million
  • TABLE 11 North America CVD Health Informatics Market by Country, 2022 - 2028, USD Million
  • TABLE 12 North America Cardiac Rehab Programs Market by Country, 2018 - 2021, USD Million
  • TABLE 13 North America Cardiac Rehab Programs Market by Country, 2022 - 2028, USD Million
  • TABLE 14 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 15 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 16 North America Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 17 North America Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 18 North America Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 19 North America Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 20 North America Ambulatory Care Centers Market by Country, 2018 - 2021, USD Million
  • TABLE 21 North America Ambulatory Care Centers Market by Country, 2022 - 2028, USD Million
  • TABLE 22 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 23 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 24 North America Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 25 North America Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 26 North America Cloud-Based Market by Country, 2018 - 2021, USD Million
  • TABLE 27 North America Cloud-Based Market by Country, 2022 - 2028, USD Million
  • TABLE 28 North America On-premise Market by Country, 2018 - 2021, USD Million
  • TABLE 29 North America On-premise Market by Country, 2022 - 2028, USD Million
  • TABLE 30 North America Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 31 North America Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 32 North America Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 33 North America Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 34 North America Software Market by Country, 2018 - 2021, USD Million
  • TABLE 35 North America Software Market by Country, 2022 - 2028, USD Million
  • TABLE 36 North America Cardiovascular Digital Solutions Market by Country, 2018 - 2021, USD Million
  • TABLE 37 North America Cardiovascular Digital Solutions Market by Country, 2022 - 2028, USD Million
  • TABLE 38 US Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 39 US Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 40 US Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 41 US Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 42 US Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 43 US Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 44 US Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 45 US Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 46 US Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 47 US Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 48 Canada Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 49 Canada Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 50 Canada Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 51 Canada Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 52 Canada Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 53 Canada Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 54 Canada Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 55 Canada Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 56 Canada Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 57 Canada Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 58 Mexico Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 59 Mexico Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 60 Mexico Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 61 Mexico Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 62 Mexico Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 63 Mexico Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 64 Mexico Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 65 Mexico Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 66 Mexico Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 67 Mexico Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 68 Rest of North America Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 69 Rest of North America Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 70 Rest of North America Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 71 Rest of North America Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 72 Rest of North America Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 73 Rest of North America Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 74 Rest of North America Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 75 Rest of North America Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 76 Rest of North America Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 77 Rest of North America Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 78 Key Information - Apple, Inc.
  • TABLE 79 KEY INFORMATION - GENERAL ELECTRIC Company
  • TABLE 80 Key Information - Koninklijke Philips N.V.
  • TABLE 81 Key Information - Verily Life Sciences LLC
  • TABLE 82 key information - iRhythm Technologies, Inc.
  • TABLE 83 Key Information - Bardy Diagnostics, Inc
  • TABLE 84 Key Information - eviCore Healthcare
  • TABLE 85 Key Information - AliveCor, Inc.
  • TABLE 86 Key Information - Cardiotrack
  • TABLE 87 Key Information - HeartFlow, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, aug - 2022, nov) Leading Players
  • FIG 5 SWOT Analysis: apple, Inc.
  • FIG 6 Recent strategies and developments: General Electric Company
  • FIG 7 Recent strategies and developments: Koninklijke Philips N.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!